A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.
The Advisory Council on the Misuse of Drugs (ACMD) will carry out a formal review of the regulatory framework around cannabis-based medicinal products.
